0 CHECKOUT

In Vitro Diagnostics (IVD) Market by Product Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020

  • ID: 3345862
  • July 2015
  • Region: Global
  • 272 Pages
  • Markets and Markets
The Global IVD Market Is Expected To Reach USD 75.1 Billion By 2020, Growing At A CAGR Of 5.8% During The Forecast Period (2015 To 2020)

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Biomérieux
  • Danaher Corporation
  • Johnson And Johnson
  • Roche Diagnostics
  • Siemens Healthcare
  • MORE

In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020.

In vitro diagnostics (IVD) testing is an indispensable tool in the modern medical practice. IVD tests are conducted to diagnose a number of diseases. With the evolution of biotechnology, there has been a drastic change in the type of tests conducted for diagnosing various diseases; this helped physicians across the globe to diagnose and treat diseases promptly and effectively. The increasing usage of self-testing kits is the most important trend witnessed recently in the IVD industry is that of

The global IVD market is expected to reach USD 75.1 billion by 2020, growing at a CAGR of 5.8% during the forecast period (2015 to 2020). The market is mainly driven by the rising incidences of chronic lifestyle diseases in emerging economies, growing aging population, and rising adoption of point-of-care testing and personalized medicine.

In this report, the market is segmented by product, technology, application, end user, READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Biomérieux
  • Danaher Corporation
  • Johnson And Johnson
  • Roche Diagnostics
  • Siemens Healthcare
  • MORE

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown Of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown And Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions For The Study

3 Executive Summary

4 Premium Insights
4.1 Growth Potential Of The Ivd Market
4.2 Asia-Pacific: Ivd Market
4.3 Ivd Market: Geographic Snapshot
4.4 Geographic Mix: Ivd Market, By Technology
4.5 Ivd Market: Emerging Vs. Developed Markets

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 In Vitro Diagnostics Market, By Product
5.2.2 In Vitro Diagnostics Market, By Technology
5.2.3 In Vitro Diagnostics Market, By Application
5.2.4 In Vitro Diagnostics Market, By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Incidence Of Chronic Lifestyle Diseases Across The Globe
5.3.1.2 Rapid Growth In The Geriatric Population
5.3.1.3 Increasing Adoption Of Point-Of-Care (POC) Testing
5.3.1.4 Growing Awareness Of Personalized Medicine
5.3.2 Restraints
5.3.2.1 Inadequate Reimbursement
5.3.2.2 Implementation Of Excise Duty By The U.S. Government
5.3.3 Opportunities
5.3.3.1 New Range Of Condition-Specific Markers And Tests With Advances In Genomics And Proteomics
5.3.3.2 Emerging Economies With Increasing Investments
5.3.4 Challenges
5.3.4.1 Stringent Regulatory Framework

6 Industry Insights
6.1 Introduction
6.2 Acquisitions From Leading Players Resulting In Consolidation Of The Ivd Market
6.3 Porter’S Five Force Analysis
6.3.1 Threat Of New Entrants
6.3.2 Threat Of Substitutes
6.3.3 Bargaining Power Of Suppliers
6.3.4 Bargaining Power Of Buyers
6.3.5 Intensity Of Competitive Rivalry
6.4 Regulatory Overview
6.4.1 North America
6.4.1.1 U.S.
6.4.1.2 Canada
6.4.2 Europe
6.4.3 Asia-Pacific
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 India
6.4.3.4 Australia

7 Global Ivd Market, By Product & Service
7.1 Introduction
7.2 Reagents & Kits
7.3 Instruments
7.4 Data Management Software
7.5 Services

8 Global Ivd Market, By Technology
8.1 Introduction
8.2 Clinical Chemistry
8.2.1 Basic Metabolic Panels
8.2.2 Electrolyte Panels
8.2.3 Liver Panels
8.2.4 Lipid Profiles
8.2.5 Renal Profiles
8.2.6 Thyroid Function Panels
8.2.7 Specialty Chemical Tests
8.3 Immunochemistry/Immunoassays
8.3.1 Enzyme Linked Immunosorbent Assay (Elisa)
8.3.1.1 Chemiluminescence Immunoassays (Clias)
8.3.1.2 Fluorescence Immunoassays (Fia)
8.3.1.3 Colorimetric Immunoassays (Ci)
8.3.2 Radioimmunoassays (Ria)
8.3.3 Rapid Tests
8.3.4 Western Blot
8.3.5 Enzyme Linked Immunospot Assay (Elispot)
8.4 Hematology
8.5 Coagulation And Hemostasis
8.6 Microbiology
8.7 Molecular Diagnostics (Mdx)
8.7.1 Polymerase Chain Reaction (Pcr)
8.7.2 Isothermal Nucleic Acid Amplification Technology (Inaat)
8.7.3 Microarrays
8.7.4 Hybridization
8.7.5 Dna Sequencing & Next-Generation Sequencing
8.7.6 Other Mdx Technologies
8.8 Other Ivd Technologies

9 In Vitro Diagnostics Market, By Application
9.1 Introduction
9.2 Diabetes
9.3 Infectious Diseases
9.4 Oncology/Cancer
9.5 Cardiology
9.6 Nephrology
9.7 Autoimmune Diseases
9.8 Drug Testing
9.9 Hiv/Aids
9.10 Other Applications

10 Global Ivd Market, By End User
10.1 Introduction
10.2 Laboratories
10.3 Hospitals
10.4 Academic Institutes
10.5 Point-Of-Care Testing
10.6 Patient Self-Testing
10.7 Others

11 Geographic Analysis
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Russia
11.3.7 Rest Of Europe (ROE)
11.4 Asia-Pacific (APAC)
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest Of Asia-Pacific (ROAPAC)
11.5 Rest Of The World (ROW)
11.5.1 Latin America
11.5.1.1 Brazil
11.5.1.2 Mexico
11.5.1.3 Rest Of Latin America (ROLA)
11.5.2 Middle East And Africa

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation And Trends
12.4 New Product Launches
12.5 Agreements, Partnerships, And Collaborations
12.6 Mergers And Acquisitions
12.7 Expansions

13 Company Profiles
13.1 Abbott Laboratories, Inc.
13.2 Danaher Corporation
13.3 Johnson And Johnson
13.4 Roche Diagnostics
13.5 Siemens Healthcare
13.6 Becton, Dickinson And Company
13.7 Biomérieux
13.8 Bio-Rad Laboratories, Inc.
13.9 Ortho Clinical Diagnostics, Inc.
13.10 Sysmex Corporation
13.11 Thermo Fisher Scientific, Inc.
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

14 Appendix
14.1 Insights Of Industry Experts
14.2 Discussion Guide
14.3 Other Developments, 2012–2015
14.4 Introducing Rt: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports

List Of Tables

Table 1 Increased Incidence Of Chronic Lifestyle Diseases And Rapid Growth In Geriatric Population Will Drive The Market Growth
Table 2 Lack Of Reimbursement And Implementation Of Excise Duty To Restrain The Market Growth
Table 3 Emerging Economies With Increasing Investments Offer Significant Opportunities For Market Growth
Table 4 Stringent Regulations Continue To Be A Key Challenge For The Ivd Market
Table 5 Global Ivd Market, By Product & Service, 2013–2020 (USD Million)
Table 6 Global Ivd Reagents & Kits Market Size, By Country,
2013–2020 (USD Million)
Table 7 Global Ivd Reagents & Kits Market Size, By Technology,
2013–2020 (USD Million)
Table 8 Global Ivd Instruments Market Size, By Country,
2013–2020 (USD Million)
Table 9 Global Ivd Instruments Market Size, By Technology,
2013–2020 (USD Million)
Table 10 Global Data Management Software Market Size, By Country,
2013–2020 (USD Million)
Table 11 Global Ivd Data Management Software Market Size, By Technology, 2013–2020 (USD Million)
Table 12 Global Ivd Services Market Size, By Country, 2013–2020 (USD Million)
Table 13 Global Ivd Services Market Size, By Technology,
2013–2020 (USD Million)
Table 14 Global Ivd Market, By Technology, 2013 – 2020 (USD Million)
Table 15 Global Clinical Chemistry Market Size, By Country,
2013–2020 (USD Million)
Table 16 Global Clinical Chemistry Market Size, By Test, 2013–2020 (USD Million)
Table 17 Global Basic Metabolic Panels Market Size, By Country,
2013–2020 (USD Million)
Table 18 Global Electrolyte Panels Market Size, By Country,
2013–2020 (USD Million)
Table 19 Global Liver Panels Market Size, By Country, 2013–2020 (USD Million)
Table 20 Global Lipid Profiles Market Size, By Country, 2013–2020 (USD Million)
Table 21 Global Renal Profiles Market Size, By Country,
2013–2020 (USD Million)
Table 22 Global Thyroid Function Panels Market Size, By Country,
2013–2020 (USD Million)
Table 23 Global Specialty Chemical Tests Market Size, By Country,
2013–2020 (USD Million)
Table 24 Global Immunoassay/Immunochemistry Market Size, By Type,
2013–2020 (USD Million)
Table 25 Global Immunoassay/Immunochemistry Market Size, By Country,
2013–2020 (USD Million)
Table 26 Global Elisa Market Size, By Country, 2013–2020 (USD Million)
Table 27 Global Elisa Market Size, By Type, 2013–2020 (USD Million)
Table 28 Global Chemiluminescence Immunoassays (Clia) Market Size, By Country, 2013–2020 (USD Million)
Table 29 Global Fluorescence Immunoassays Market Size, By Country,
2013–2020 (USD Million)
Table 30 Global Colorimetric Immunoassays Market Size, By Country,
2013–2020 (USD Million)
Table 31 Global Radioimmunoassays Market Size, By Country,
2013–2020 (USD Million)
Table 32 Global Rapid Tests Market Size, By Country, 2013–2020 (USD Million)
Table 33 Global Western Blot Market Size, By Country, 2013–2020 (USD Million)
Table 34 Global Elispot Market Size, By Country, 2013–2020 (USD Million)
Table 35 Global Hematology Market Size, By Country, 2013–2020 (USD Million)
Table 36 Global Coagulation & Hemostasis Market Size, By Country,
2013–2020 (USD Million)
Table 37 Global Microbiology Market Size, By Country, 2013–2020 (USD Million)
Table 38 Global Molecular Diagnostics Market Size, By Country,
2013–2020 (USD Million)
Table 39 Global Molecular Diagnostics Market Size, By Technology,
2013–2020 (USD Million)
Table 40 Global Pcr Market Size For Molecular Diagnostics, By Country,
2013–2020 (USD Million)
Table 41 Global Inaat Market Size For Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 42 Global Microarrays Market Size For Molecular Diagnostics,
By Country, 2013–2020 (USD Million)
Table 43 Global Hybridization Market Size For Molecular Diagnostics,
By Country, 2013–2020 (USD Million)
Table 44 Global Dna Sequencing & Ngs Market Size For Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 45 Global Other Mdx Technologies Market Size For Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 46 Global Other Ivd Technologies Market Size, By Country,
2013–2020 (USD Million)
Table 47 Global Ivd Market Size, By Application, 2013 – 2020 (USD Million)
Table 48 Global Diabetic Patient Population (2014)
Table 49 Global Ivd Market Size For Diabetes, By Country,
2013–2020 (USD Million)
Table 50 Global Ivd Market Size For Infectious Diseases, By Country,
2013–2020 (USD Million)
Table 51 Global Ivd Market Size For Oncology, By Country,
2013–2020 (USD Million)
Table 52 Global Ivd Market Size For Cardiology, By Country,
2013–2020 (USD Million)
Table 53 Global Ivd Market Size For Nephrology, By Country,
2013–2020 (USD Million)
Table 54 Global Ivd Market Size For Autoimmune Diseases, By Country,
2013–2020 (USD Million)
Table 55 Global Ivd Market Size For Drug Testing, By Country,
2013–2020 (USD Million)
Table 56 Global Ivd Market Size For Hiv/Aids, By Country, 2013–2020 (USD Million)
Table 57 Global Ivd Market Size For Other Applications, By Country,
2013–2020 (USD Million)
Table 58 Global Ivd Market, By End User, 2013–2020 (USD Million)
Table 59 Global Ivd Market Size For Laboratories, By Country,
2013–2020 (USD Million)
Table 60 Global Ivd Market Size For Hospitals, By Country,
2013–2020 (USD Million)
Table 61 Global Ivd Market Size For Academic Institutes, By Country,
2013–2020 (USD Million)
Table 62 Global Ivd Market Size For Poc Testing, By Country,
2013–2020 (USD Million)
Table 63 Global Ivd Market Size For Patient Self-Testing, By Country,
2013–2020 (USD Million)
Table 64 Global Ivd Market Size For Other End Users, By Country,
2013–2020 (USD Million)
Table 65 Global Ivd Market Size, By Region, 2013–2020 (USD Million)
Table 66 Global Ivd Market Size, By Country, 2013–2020 (USD Million)
Table 67 North America: Ivd Market Size, By Country, 2013–2020 (USD Million)
Table 68 North America: Ivd Market Size, By Product & Services
2013–2020 (USD Million)
Table 69 North America: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 70 North America: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 71 North America: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 72 U.S.: Ivd Market Size, By Product & Services, 2013–2020 (USD Million)
Table 73 U.S.: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 74 U.S.: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 75 U.S.: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 76 Canada: Ivd Market Size, By Product & Services,
2013–2020 (USD Million)
Table 77 Canada: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 78 Canada: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 79 Canada: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 80 Europe: Ivd Market Size, By Country, 2013–2020 (USD Million)
Table 81 Europe: Ivd Market Size, By Product & Services,
2013–2020 (USD Million)
Table 82 Europe: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 83 Europe: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 84 Europe: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 85 Germany: Ivd Market Size, By Product & Services,
2013–2020 (USD Million)
Table 86 Germany: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 87 Germany: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 88 Germany: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 89 France: Ivd Market Size, By Product & Services, 2013–2020 (USD Million)
Table 90 France: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 91 France: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 92 France: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 93 U.K.: Ivd Market Size, By Product & Services, 2013–2020 (USD Million)
Table 94 U.K.: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 95 U.K.: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 96 U.K.: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 97 Italy: Ivd Market Size, By Product & Services, 2013–2020 (USD Million)
Table 98 Italy: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 99 Italy: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 100 Italy: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 101 Spain: Ivd Market Size, By Product & Services, 2013–2020 (USD Million)
Table 102 Spain: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 103 Spain: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 104 Spain: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 105 Russia: Ivd Market Size, By Product & Services, 2013–2020 (USD Million)
Table 106 Russia: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 107 Russia: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 108 Russia: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 109 Roe: Ivd Market Size, By Product & Services, 2013–2020 (USD Million)
Table 110 Roe: Ivd Market Size, By Application, 2013–2020 (USD Million)
Table 111 Roe: Ivd Market Size, By Technology, 2013–2020 (USD Million)
Table 112 Roe: Ivd Market Size, By End User, 2013–2020 (USD Million)
Table 113 Apac: Ivd Market Size, By Country, 2013-2020 (USD Million)
Table 114 Apac: Ivd Market Size, By Product & Services, 2013-2020 (USD Million)
Table 115 Apac: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 116 Apac: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 117 Apac: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 118 Japan: Ivd Market Size, By Product & Services, 2013-2020 (USD Million)
Table 119 Japan: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 120 Japan: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 121 Japan: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 122 China: Ivd Market Size, By Product & Services, 2013-2020 (USD Million)
Table 123 China: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 124 China: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 125 China: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 126 India: Ivd Market Size, By Product & Services, 2013-2020 (USD Million)
Table 127 India: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 128 India: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 129 India: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 130 Roapac: Ivd Market Size, By Product & Services, 2013-2020 (USD Million)
Table 131 Roapac: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 132 Roapac: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 133 Roapac: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 134 Row: Ivd Market Size, By Region, 2013-2020 (USD Million)
Table 135 Row: Ivd Market Size, By Product & Services, 2013-2020 (USD Million)
Table 136 Row: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 137 Row: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 138 Row: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 139 Latin America: Ivd Market Size, By Country, 2013-2020 (USD Million)
Table 140 Latin America: Ivd Market Size, By Product & Services,
2013-2020 (USD Million)
Table 141 Latin America: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 142 Latin America: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 143 Latin America: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 144 Brazil: Ivd Market Size, By Product & Services, 2013-2020 (USD Million)
Table 145 Brazil: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 146 Brazil: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 147 Brazil: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 148 Mexico: Ivd Market Size, By Product & Services, 2013-2020 (USD Million)
Table 149 Mexico: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 150 Mexico: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 151 Mexico: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 152 Rola: Ivd Market Size, By Product & Services, 2013-2020 (USD Million)
Table 153 Rola: Ivd Market Size, By Application, 2013-2020 (USD Million)
Table 154 Rola: Ivd Market Size, By Technology, 2013-2020 (USD Million)
Table 155 Rola: Ivd Market Size, By End User, 2013-2020 (USD Million)
Table 156 Middle East And Africa: Ivd Market Size, By Product & Services,
2013-2020 (USD Million)
Table 157 Middle East And Africa: Ivd Market Size, By Application,
2013-2020 (USD Million)
Table 158 Middle East And Africa: Ivd Market Size, By Technology,
2013-2020 (USD Million)
Table 159 Middle East And Africa: Ivd Market Size, By End User,
2013-2020 (USD Million)
Table 160 New Product Launches, 2012–2015
Table 161 Agreements, Partnerships, And Collaborations, 2012–2015
Table 162 Mergers And Acquisitions, 2012–2015
Table 163 Expansions, 2012–2015

List Of Figures

Figure 1 Global In Vitro Diagnostics Market
Figure 2 Research Design
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global IVD Market Size, By Products & Services,
2015 Vs. 2020 (USD Million)
Figure 8 Global IVD Market Size, By Application, 2015 Vs. 2020 (USD Million)
Figure 9 Global IVD Market Size, By End User, 2015 Vs. 2020 (USD Million)
Figure 10 IVD Market: Geographic Snapshot
Figure 11 China And India To Drive The Growth Of The IVD Market In
Asia-Pacific Region
Figure 12 Increasing Incidence Of Chronic Lifestyle Diseases Is Driving Growth In The IVD Market
Figure 13 Reagents & Kits To Account For The Largest Share Of The IVD Market In North America
Figure 14 U.S. To Command More Than One-Third Of The Global IVD Market
Figure 15 North America To Dominate The Molecular Diagnostics & Microbiology Markets
Figure 16 Emerging Markets Are Estimated To Grow At A Higher Rate During The Forecast Period
Figure 17 In Vitro Diagnostics Market Segmentation, By Product
Figure 18 In Vitro Diagnostics Market Segmentation, By Technology
Figure 19 In Vitro Diagnostics Market Segmentation, By Application
Figure 20 In Vitro Diagnostics Market Segmentation, By End User
Figure 21 IVD Market: Drivers, Restraints, Opportunities, & Challenges
Figure 22 Porter’S Five Force Analysis
Figure 23 Regulatory Approval Process In China
Figure 24 Regulatory Approval Process In India
Figure 25 Reagents & Kits The Fastest Growing Segment Of The IVD Market
Figure 26 Molecular Diagnostics Will Grow At The Highest Cagr During The Forecast Period Of 2015-2020
Figure 27 Oncology Is The Fastest-Growing Segment Of The IVD Market
Figure 28 Global IVD Market Size, By End User, 2015 Vs. 2020 (USD Million)
Figure 29 North America To Dominate The IVD Market
Figure 30 North American IVD Market Overview
Figure 31 European IVD Market Overview
Figure 32 Players Majorly Adopted The Strategy Of New Product Launches From 2012 To 2015
Figure 33 Global In Vitro Diagnostics Market Share Analysis, By Key Player, 2014
Figure 34 Battle For Market Share: New Product Launches Was The Key Strategy
Figure 35 Geographic Revenue Mix Of The Top 5 Market Players
Figure 36 Company Snapshot: Abbott Laboratories, Inc.
Figure 37 Company Snapshot: Danaher Corporation
Figure 38 Company Snapshot: Johnson And Johnson
Figure 39 Company Snapshot: F. Hoffmann-La Roche Ltd.
Figure 40 Company Snapshot: Siemens AG
Figure 41 Company Snapshot: Becton, Dickinson And Company
Figure 42 Company Snapshot: Biomérieux
Figure 43 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 44 Company Snapshot: Sysmex Corporation
Figure 45 Company Snapshot: Thermo Fisher Scientific, Inc.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Biomérieux
  • Danaher Corporation
  • Johnson And Johnson
  • Roche Diagnostics
  • Siemens Healthcare
  • MORE

The global in vitro diagnostics market is estimated to reach $75.1 billion by 2020, growing at a CAGR of 5.8% during the forecast period (2015 to 2020). This market is mainly driven by the rising incidences of chronic lifestyle diseases and infectious diseases in emerging economies, rapidly aging population, and increasing adoption of point-of-care testing practices, and growing awareness of personalized medicine. In addition, extending reach of molecular diagnostics and new range of condition-specific markers and tests with advances in genomics and proteomics are creating new opportunities for this market. However, stringent regulatory framework and inadequate reimbursement are restraining the growth of this market.

In this report, the market is segmented on the basis of product, technology, application, end user, and region. The research report discusses the key market drivers, restraints, opportunities, and challenges in this global market and its submarkets.

On the basis of products, the market is segmented into reagents, instruments, services, and data management system/software. In 2014, the reagents segment accounted for the largest share of ~80% of the In Vitro Diagnostics market; this segment is poised to grow at a CAGR of 6.4% during the forecast period. The growth in this market is attributed to the growing demand for reagents in line with an increasing number of diagnostic tests being performed globally every year, and increasing uptake of new reagents that are highly sensitive and provide faster and accurate results.

On the basis of applications, this market is segmented into diabetes, infectious diseases, oncology, cardiology, HIV/AIDS, autoimmune diseases, drug testing, nephrology, and other applications. The infectious diseases segment accounted for the largest share of ~25% of the In Vitro Diagnostics market in 2014.

In this report, this global market is studied at regional and country levels. In 2014, North America commanded the largest share of the market, and this region is poised to dominate the market during the forecast period. However, the Asia-Pacific region is expected to be the fastest-growing regional market in the coming years. The growth in this region is attributed to the increasing investment by leading players, and respective government agencies, and increasing demand for diagnostic tests from large patient population in the region.

The major players in the global In Vitro Diagnostics market are Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickson and Company (U.S.), Johnson and Johnson (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), and bioMérieux (France).

Note: Product cover images may vary from those shown

- Abbott Laboratories, Inc.
- Becton, Dickinson And Company
- Bio-Rad Laboratories, Inc.
- Biomérieux
- Danaher Corporation
- Johnson And Johnson
- Ortho Clinical Diagnostics, Inc.
- Roche Diagnostics
- Siemens Healthcare
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • STILLE Surgical Instruments
  • Alcon Incorporated
  • Hoya Surgical Optics, Inc.
  • Hollister Inc.
  • PerkinElmer, Inc.
  • Cyberonics, Inc.